- Price
- $269.99
- Day
- -0.09%
- Mkt Cap
- $650.65B
- 52W Range
- $174.12 – $281.07
- Volume
- 16.09M
- Beta
- 0.23
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Retirement portfolios need income that shows up on time, grows faster than inflation, and does not blink during a downturn.
Read full article
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges. I rank the Dividend Kings using my 9F Quality Scores, blending qualitative and quantitative factors for a robust, investment-grade assessment. ADP stands out as the best total-return candidate. It is undervalued, high-quality, and offering a strong projected dividend growth rate and Adjusted Chowder Number.
Read full article
Younger investors are rewriting the rules of wealth building, and five overlooked dividend stocks under $20 sit right at the center of that shift. The real question is whether these picks can hold up long enough to matter.
Read full article
Nykredit A S bought a new position in shares of Johnson and Johnson (NYSE: JNJ) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 928,551 shares of the company's stock, valued at approximately $235,824,000. Johnson and Johnson accounts for 0.7% of Nykredit A
Read full article
Building a $100,000 dividend snowball is foundational for financial security and passive income. I detail how I would go about doing so in today's rising rate environment. I also share some specific picks and how to allocate capital on a percentage basis to build the snowball.
Read full article
JNJ's growth gets a boost from new drug launches and pipeline wins, but Stelara's patent loss and MedTech headwinds remain key risks.
Read full article
Smith Chas P and Associates PA Cpas decreased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 2.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 245,396 shares of the company's stock after selling 6,543 shares during the quarter.
Read full article
In the most recent trading session, Johnson & Johnson (JNJ) closed at $270.22, indicating a +1.1% shift from the previous trading day.
Read full article
U S Wealth Group LLC. raised its stake in Johnson and Johnson (NYSE: JNJ) by 15.1% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 17,259 shares of the company's stock after purchasing an additional 2,266 shares during the period. Johnson and Johnson accounts for approximately
Read full article
Fed uncertainty, oil prices, and macro pressures are bringing inflation and interest-rate fears to a head; investors are fleeing to dividends, and for good reason. Dividends provide steady, reliable income and returns regardless of market volatility.
Read full article
Talon Private Wealth LLC grew its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 89.5% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,588 shares of the company's stock after purchasing an additional 5,002 shares during
Read full article
Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Read full article